http://www.nextprot.org/nanopubs#NX_P84022-3_MUTAGEN_108_108.RADkrrCRpkpL-v-fqwTWOi45YlK8Kud3EaNGY6SUOu2hE
type: Nanopublication
created: 2014-09-19T00:00:00.0Z
rights: http://creativecommons.org/licenses/by/3.0/
rights holder: nextprot.org
used data: neXtProt database
authored by: CALIPHO project
authored by: http://orcid.org/0000-0001-6710-1373
authored by: 0000-0001-6818-334X
authored by: http://orcid.org/0000-0002-1303-2189
authored by: http://orcid.org/0000-0003-1813-6857
version number: 1

http://www.nextprot.org/nanopubs#NX_P84022-3_MUTAGEN_108_108.RADkrrCRpkpL-v-fqwTWOi45YlK8Kud3EaNGY6SUOu2hE._1
type: SO_0001148
type: RangedSequencePosition
comment: Reduced phosphorylation. Increased transcriptional and antiproliferative activities. Further increase in transcriptional and antiproliferative activities; when associated with V-8 and V-179.

http://www.nextprot.org/nanopubs#NX_P84022-3_MUTAGEN_108_108.RADkrrCRpkpL-v-fqwTWOi45YlK8Kud3EaNGY6SUOu2hE._2
SIO_000300: 108
type: StartPosition

http://www.nextprot.org/nanopubs#NX_P84022-3_MUTAGEN_108_108.RADkrrCRpkpL-v-fqwTWOi45YlK8Kud3EaNGY6SUOu2hE._3
SIO_000300: 108
type: EndPosition

http://www.nextprot.org/nanopubs#NX_P84022-3_MUTAGEN_108_108.RADkrrCRpkpL-v-fqwTWOi45YlK8Kud3EaNGY6SUOu2hE.assertion
comment: Mutagenesis site occurs in NX_P84022-3 at amino acids 108 - 108.
used data: P84022
evidence: neXtProt gold
type: ECO_0000006
type: ECO_0000200

neXtProt gold
type: ECO_0000205